| Literature DB >> 22321609 |
Ramakrishna U Rao1, Yuefang Huang, Sahar Abubucker, Michael Heinz, Seth D Crosby, Makedonka Mitreva, Gary J Weil.
Abstract
BACKGROUND: Most filarial nematodes contain Wolbachia symbionts. The purpose of this study was to examine the effects of doxycycline on gene expression in Wolbachia and adult female Brugia malayi.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22321609 PMCID: PMC3352068 DOI: 10.1186/1423-0127-19-21
Source DB: PubMed Journal: J Biomed Sci ISSN: 1021-7770 Impact factor: 8.410
In vivo effects of doxycycline on Brugia malayi microfilaria (MF) and adult worms
| Stage | % of pretreatment MF counts (mean ± SD) | Mean (± SD) number of worms | ||||
|---|---|---|---|---|---|---|
| 7 | 14 | 28 | 42 | 42 | ||
| Treated | MF | 121 ± 74 | 119 ± 30 | 200 ± 95 | 192 ± 101 | - |
| Control | MF | 167 ± 135 | 90 ± 18 | 143 ± 108 | 112 ± 92 | - |
| Treated | Adult worm | - | - | - | - | 29.3 ± 18 (15) |
| Control | Adult worm | - | - | - | - | 34.5 ± 10 |
Gerbils (n = 6) were treated with doxycycline (100 mg/kg/bw/per os). Controls were untreated. During 6 weeks of treatment, on day 7, 14, 28, and 42 no significant reduction in MF counts was observed. Reduction in worm recovery at the end of the treatment between control and treated gerbils was not significant.
Figure 1Transmission electron micrographs of . Panel A and C are sections of untreated female worm. Panel A shows numerous Wolbachia (arrows) in the hypodermis. Panel C shows, intact embryos in the uterus. Panel B and D are sections from doxycycline treated worms. The hypodermis is free of Wolbachia (Panel B) and only degenerate embryos were present in the uterus of treated worms (Panel D). U, uterus; C, cuticle; UW, uterine wall; MF, microfilaria; mtr, mitochondria. Scale bar = 1 μm.
Description of top 20 differentially expressed Wolbachia genes found in doxycycline treated Brugia malayi female worms
| Functional class | Systematic | Annotation# | Fold change | P-value | Signal | Description |
|---|---|---|---|---|---|---|
| BMX14197 | 0.12 | 1.84E-05 | Down | DNA-directed RNA polymerase sigma 32 subunit, RpoH | ||
| BMX14096 | 0.11 | 4.19E-05 | Down | Ribosomal protein S14 | ||
| BMX14288 | 0.23 | 7.90E-05 | Down | Ribosomal protein S21 | ||
| BMX14418 | 0.12 | 9.18E-05 | Down | Ribosomal protein L1 | ||
| BMX14100 | 0.10 | 9.84E-05 | Down | Ribosomal protein S17 | ||
| BMX14101 | 0.19 | 1.01E-04 | Down | Ribosomal protein L16 | ||
| BMX14113 | 0.16 | 1.14E-04 | Down | Ribosomal protein S12 | ||
| BMX14026 | 0.21 | 5.92E-05 | Down | Ribonuclease D | ||
| BMX14200 | 0.06 | 1.56E-05 | Down | DNA polymerase III, gamma/tau subunit | ||
| BMX14193 | 0.25 | 5.30E-05 | Down | RecA recombinase | ||
| BMX14476 | 0.13 | 1.22E-04 | Down | Superfamily II DNA/RNA helicase | ||
| BMX14457 | 0.09 | 8.65E-05 | Down | F0F1-type ATP synthase, beta subunit | ||
| BMX14214 | 0.14 | 1.40E-04 | Down | Succinate dehydrogenase flavoprotein subunit, SdhA | ||
| BMX13916 | 0.23 | 1.38E-04 | Down | Kef-type K+ transport system, membrane component | ||
| BMX13899 | 0.27 | 1.09E-04 | Down | Ornithine/acetylornithine aminotransferase | ||
| BMX13796 | 0.15 | 1.06E-05 | Down | HesB/YadR/YfhF family protein | ||
| BMX14563 | 0.18 | 1.27E-04 | Down | Type IV secretory pathway, VirB6 components | ||
| BMX14198 | 0.06 | 1.21E-04 | Down | Outer surface protein-wsp | ||
Expression of listed Wolbachia genes was down-regulated and those shown in italics were up-regulated after doxycycline treatment in vivo.
Major known differentially expressed* Brugia malayi genes after doxycycline treatment
| Functional class | Sequence | OligoID | Fold change | Description | Pub_Locus | |
|---|---|---|---|---|---|---|
| Electron transfer | ||||||
| BMC05513 | bm.01224 | 5.12 | 1.04E-03 | Cytochrome C oxidase | Bm1_53760 | |
| 14963.m01788 | BMX5456 | 2.66 | 3.13E-03 | Ubiquinol-cytochrome-c oxidase activity | Bm1_34585 | |
| BMC01497 | bm.00393 | 3.55 | 6.56E-03 | ATP synthase F0 subunit 6 | ||
| Antioxidants | ||||||
| 14981.m02381 | BMX7492 | 2.85 | 1.72E-03 | Thioredoxin | Bm1_46710 | |
| Proteases | ||||||
| BMW00062.466 | BMX11239 | 3.12 | 1.42E-03 | Cathepsin L-like cysteine proteinase | Bm1_00065 | |
| 13332.m00193 | BMX1173 | 2.65 | 4.18E-03 | Metalloprotease | Bm1_07750 | |
| 13632.m00184 | BMX1614 | 2.01 | 7.91E-03 | Trypsin family protein | Bm1_10665 | |
| Metabolism and transport | ||||||
| 14773.m00936 | BMX4045 | 2.67 | 5.91E-03 | Pyruvate dehydrogenase | Bm1_25865 | |
| 13478.m00071 | BMX1447 | 2.00 | 5.55E-03 | Malate/L-lactate dehydrogenase | Bm1_09530 | |
| 14981.m02410 | BMX7517 | 3.61 | 3.27E-04 | Biopterin-dependent aromatic amino acid | Bm1_46865 | |
| 14787.m00179 | BMX4095 | 13.7 | 7.23E-06 | Cysteine-rich, acidic integral membrane protein precursor, putative | Bm1_15145 | |
| Immunogens | ||||||
| 14222.m00064 | BMX2433 | 10.3 | 2.76E-05 | PPE family protein, putative | Bm1_15875 | |
| BMC05381 | bm.01203 | 2.13 | 4.10E-03 | BmSERPIN | Bm1_03995 | |
| 12920.m00009 | BMX601 | 2.49 | 6.84E-03 | Excretory/secretory protein Juv-p120 | Bm1_04050 | |
| BMC00351 | bm.03044 | 2.27 | 2.65E-03 | Vespid venom allergen | Bm1_14040 | |
| 14399.m00013 | BMX2941 | 2.51 | 7.90E-04 | ALT protein | Bm1_14360 | |
| 13893.m00088 | BMX1920 | 4.25 | 3.08E-03 | IgG and IgE immunoreactive antigen | Bm1_12575 | |
| BMC00480 | bm.00167 | 4.40 | 2.76E-03 | mmc1 | #N/A | |
| 13673.m00036 | BMX1683 | 3.03 | 1.05E-03 | Mucin | Bm1_11110 | |
| Reproduction, development & transport | ||||||
| BMC00903 | bm.00277 | 0.47 | 2.78E-03 | Embryonic fatty acid-binding protein | Bm1_33050 | |
| 12495.m00012 | BMX108 | 0.26 | 8.99E-03 | Collagen, putative | Bm1_00775 | |
| 15377.m00007 | BMX9051 | 0.21 | 1.75E-03 | Alpha-1 collagen type IX, putative | Bm1_56350 | |
| AA109462 | BMX9336 | 0.40 | 5.12E-03 | Peptidyl-prolyl cis-trans isomerase | Bm1_56870 | |
| BMC03244 | bm.00803 | 0.45 | 4.98E-03 | Prolyl 4-hydroxylase | Bm1_45455 | |
| BMC02383 | bm.00595 | 0.44 | 6.93E-04 | Caveolin-1 | Bm1_36280 | |
| 14700.m00144 | BMX3736 | 0.42 | 4.38E-03 | Cadherin | Bm1_24010 | |
| Electron transfer | ||||||
| BMC02188 | bm.00554 | 0.30 | 2.20E-03 | NADH dehydrogenase subunit 5 | Bm1_56750 | |
Figure 2Distribution of KEGG pathways mapped to up-regulated and down-regulated . Many genes involved in transport, signaling, tanslation, metabolism and cell communication pathways were affected. Significant canonical pathways (P ≤ 0.05) and number of genes mapped in each pathway and their percentages are shown in additional file 12 for regulated genes.
Figure 3Correlation between expression values for . Normalized fold change values of microarray experiment and 2-ΔΔ Ct values of qRT-PCR obtained for the same genes were Log transformed and analysed by the nonparametric Spearman rank correlation test (R = 0.4352; P = 0.007).